Karl Göran Ronquist
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Karl Göran Ronquist has a total of 100 co-authors. Here are the top co-authors by number of shared publications:
Gunnar Ronquist
12 shared publicationsAnders Larsson
10 shared publicationsLouise Dubois
6 shared publications- Anders Larsson
Department of Medical Sciences, Uppsala University, Uppsala University Hospital, 75185 Uppsala, Sweden
4 shared publications - Anders Waldenström
Department of Public Health and Clinical Medicine/Medicine, Umeå University, Umeå, Sweden
4 shared publications Bo Ek
§Department of Analytical Chemistry, Science for Life Laboratory, Uppsala University, 751 24 Uppsala, Sweden
4 shared publications
Latest Publications
- Open Access
Coincident Fluorescence‐Burst Analysis of the Loading Yields of Exosome‐Mimetic Nanovesicles with Fluorescently‐Labeled Cargo Molecules
The possible targeting functionality and low immunogenicity of exosomes and exosome‐like nanovesicles make them promising as drug‐delivery carriers. To tap into this potential, accurate non‐destructive methods to load them and characterize their contents are of utmost importance. However, the small size, polydispersity, and aggregation of nanovesicles in solution make quantitative characterizations of their loading particularly challenging. Here, an ad‐hoc methodology is developed based on burst analysis of dual‐color confocal fluorescence microscopy experiments, suited for quantitative characterizations of exosome‐like nanovesicles and of their fluorescently‐labeled loading. It is applied to study exosome‐mimetic nanovesicles derived from animal extracellular‐vesicles and human red blood cell detergent‐resistant membranes, loaded with fluorescently‐tagged dUTP cargo molecules. For both classes of nanovesicles, successful loading is proved and by dual‐color coincident fluorescence burst analysis, size statistics and loading yields are retrieved and quantified. The procedure affords single‐vesicle characterizations well‐suited for the investigation of a variety of cargo molecules and biological nanovesicle combinations besides the proof‐of‐principle demonstrations of this study. The results highlight a powerful characterization tool essential for optimizing the loading process and for advanced engineering of biomimetic nanovesicles for therapeutic drug delivery.
Open AccessCoincident Fluorescence‐Burst Analysis of the Loading Yields of Exosome‐Mimetic Nanovesicles with Fluorescently‐Labeled Cargo Molecules
The possible targeting functionality and low immunogenicity of exosomes and exosome‐like nanovesicles make them promising as drug‐delivery carriers. To tap into this potential, accurate non‐destructive methods to load them and characterize their contents are of utmost importance. However, the small size, polydispersity, and aggregation of nanovesicles in solution make quantitative characterizations of their loading particularly challenging. Here, an ad‐hoc methodology is developed based on burst analysis of dual‐color confocal fluorescence microscopy experiments, suited for quantitative characterizations of exosome‐like nanovesicles and of their fluorescently‐labeled loading. It is applied to study exosome‐mimetic nanovesicles derived from animal extracellular‐vesicles and human red blood cell detergent‐resistant membranes, loaded with fluorescently‐tagged dUTP cargo molecules. For both classes of nanovesicles, successful loading is proved and by dual‐color coincident fluorescence burst analysis, size statistics and loading yields are retrieved and quantified. The procedure affords single‐vesicle characterizations well‐suited for the investigation of a variety of cargo molecules and biological nanovesicle combinations besides the proof‐of‐principle demonstrations of this study. The results highlight a powerful characterization tool essential for optimizing the loading process and for advanced engineering of biomimetic nanovesicles for therapeutic drug delivery.
- Open Access
Coincident Fluorescence Burst Analysis of dUTP-Loaded Exosome-Mimetic Nanovesicles
The targeting functionality and low immunogenicity of exosomes and exosome-mimetic nanovesicles make them promising as drug-delivery carriers. To tap into this potential, accurate non-destructive methods to load them and characterize their contents are of utmost importance. However, their small size, polydispersity and aggregation in solution make quantitative characterizations of their loading particularly challenging. Here we develop an ad-hoc methodology based on a burst analysis of dual-color confocal fluorescence microscopy experiments, suited for quantitative characterizations of exosome-like nanovesicles and of their loading. We apply it to study bioengineered nanovesicles, loaded with dUTP cargo molecules, synthetized from detergent-resistant membranes of animal extracellular vesicles and human red blood cells. For both classes of bioengineered nanovesicles we prove, by means of dual-color fluorescence cross-correlation spectroscopy (FCCS), successful loading. Furthermore, by a dual-color coincident fluorescence burst (DC-CFB) analysis of the experimental data, we retrieve size and loading statistics for both types of nanovesicles. The procedure affords single-vesicle characterizations, which are essential for reliable quantitative studies of loading processes in exosomes and exosome-mimetic nanovesicles, especially in light of the typically high heterogeneity of their populations. Moreover, the method implementation can be easily adapted to the investigation of a variety of combinations of different cargo molecules and biological nanovesicles besides the proof-of-principle demonstrations considered in this study. The results provide a powerful characterization tool, well-suited for the optimization of loading processes of biomimetic nanovesicles and their advanced engineering for therapeutic drug delivery.
Open AccessCoincident Fluorescence Burst Analysis of dUTP-Loaded Exosome-Mimetic Nanovesicles
The targeting functionality and low immunogenicity of exosomes and exosome-mimetic nanovesicles make them promising as drug-delivery carriers. To tap into this potential, accurate non-destructive methods to load them and characterize their contents are of utmost importance. However, their small size, polydispersity and aggregation in solution make quantitative characterizations of their loading particularly challenging. Here we develop an ad-hoc methodology based on a burst analysis of dual-color confocal fluorescence microscopy experiments, suited for quantitative characterizations of exosome-like nanovesicles and of their loading. We apply it to study bioengineered nanovesicles, loaded with dUTP cargo molecules, synthetized from detergent-resistant membranes of animal extracellular vesicles and human red blood cells. For both classes of bioengineered nanovesicles we prove, by means of dual-color fluorescence cross-correlation spectroscopy (FCCS), successful loading. Furthermore, by a dual-color coincident fluorescence burst (DC-CFB) analysis of the experimental data, we retrieve size and loading statistics for both types of nanovesicles. The procedure affords single-vesicle characterizations, which are essential for reliable quantitative studies of loading processes in exosomes and exosome-mimetic nanovesicles, especially in light of the typically high heterogeneity of their populations. Moreover, the method implementation can be easily adapted to the investigation of a variety of combinations of different cargo molecules and biological nanovesicles besides the proof-of-principle demonstrations considered in this study. The results provide a powerful characterization tool, well-suited for the optimization of loading processes of biomimetic nanovesicles and their advanced engineering for therapeutic drug delivery.
- Open Access
- 26 August 2019
- Published by Springer Nature in Nature Communications
- Vol. 10 (1) , 1-10
Profiling surface proteins on individual exosomes using a proximity barcoding assay
Exosomes have been implicated in numerous biological processes, and they may serve as important disease markers. Surface proteins on exosomes carry information about their tissues of origin. Because of the heterogeneity of exosomes it is desirable to investigate them individually, but this has so far remained impractical. Here, we demonstrate a proximity-dependent barcoding assay to profile surface proteins of individual exosomes using antibody-DNA conjugates and next-generation sequencing. We first validate the method using artificial streptavidin-oligonucleotide complexes, followed by analysis of the variable composition of surface proteins on individual exosomes, derived from human body fluids or cell culture media. Exosomes from different sources are characterized by the presence of specific combinations of surface proteins and their abundance, allowing exosomes to be separately quantified in mixed samples to serve as markers for tissue-specific engagement in disease.
- 26 August 2019
- Published by Springer Nature in Nature Communications
- Vol. 10 (1) , 1-10
Open AccessProfiling surface proteins on individual exosomes using a proximity barcoding assay
Exosomes have been implicated in numerous biological processes, and they may serve as important disease markers. Surface proteins on exosomes carry information about their tissues of origin. Because of the heterogeneity of exosomes it is desirable to investigate them individually, but this has so far remained impractical. Here, we demonstrate a proximity-dependent barcoding assay to profile surface proteins of individual exosomes using antibody-DNA conjugates and next-generation sequencing. We first validate the method using artificial streptavidin-oligonucleotide complexes, followed by analysis of the variable composition of surface proteins on individual exosomes, derived from human body fluids or cell culture media. Exosomes from different sources are characterized by the presence of specific combinations of surface proteins and their abundance, allowing exosomes to be separately quantified in mixed samples to serve as markers for tissue-specific engagement in disease.
- Open Access
- 1 January 2019
- Published by Elsevier in Clinica Chimica Acta
- Vol. 488, 116-121
Extracellular vesicles and energy metabolism
- 1 January 2019
- Published by Elsevier in Clinica Chimica Acta
- Vol. 488, 116-121
Open AccessExtracellular vesicles and energy metabolism
- Open Access
- 20 April 2018
- Published by Cancer Research Frontiers in Cancer Research Frontiers
- Vol. 4 (1) , 13-26
Human erythrocyte-derived nanovesicles can readily be loaded with doxorubicin and act as anticancer agents.
- 20 April 2018
- Published by Cancer Research Frontiers in Cancer Research Frontiers
- Vol. 4 (1) , 13-26
Open AccessHuman erythrocyte-derived nanovesicles can readily be loaded with doxorubicin and act as anticancer agents.
- Open Access
- 1 August 2017
- Published by Elsevier in Molecular & Cellular Proteomics
- Vol. 16 (8) , 1547
Tracing Cellular Origin of Human Exosomes Using Multiplex Proximity Extension Assays
- 1 August 2017
- Published by Elsevier in Molecular & Cellular Proteomics
- Vol. 16 (8) , 1547
Open AccessTracing Cellular Origin of Human Exosomes Using Multiplex Proximity Extension Assays
- Open Access
- 29 September 2016
- Published by Springer Nature in Scientific Reports
- Vol. 6 (1) , srep34358
Detecting individual extracellular vesicles using a multicolor in situ proximity ligation assay with flow cytometric readout
Flow cytometry is a powerful method for quantitative and qualitative analysis of individual cells. However, flow cytometric analysis of extracellular vesicles (EVs) and the proteins present on their surfaces has been hampered by the small size of the EVs – in particular for the smallest EVs, which can be as little as 40 nm in diameter, the limited number of antigens present and their low refractive index. We addressed these limitations for detection and characterization of EV by flow cytometry through the use of multiplex and multicolor in situ proximity ligation assays (in situ PLA), allowing each detected EV to be easily recorded over background noise using a conventional flow cytometer. By targeting sets of proteins on the surface that are specific for distinct classes of EVs, the method allows for selective recognition of populations of EVs in samples containing more than one type of EVs. The method presented herein opens up for analyses of EVs using flow cytometry for their characterization and quantification.
- 29 September 2016
- Published by Springer Nature in Scientific Reports
- Vol. 6 (1) , srep34358
Open AccessDetecting individual extracellular vesicles using a multicolor in situ proximity ligation assay with flow cytometric readout
Flow cytometry is a powerful method for quantitative and qualitative analysis of individual cells. However, flow cytometric analysis of extracellular vesicles (EVs) and the proteins present on their surfaces has been hampered by the small size of the EVs – in particular for the smallest EVs, which can be as little as 40 nm in diameter, the limited number of antigens present and their low refractive index. We addressed these limitations for detection and characterization of EV by flow cytometry through the use of multiplex and multicolor in situ proximity ligation assays (in situ PLA), allowing each detected EV to be easily recorded over background noise using a conventional flow cytometer. By targeting sets of proteins on the surface that are specific for distinct classes of EVs, the method allows for selective recognition of populations of EVs in samples containing more than one type of EVs. The method presented herein opens up for analyses of EVs using flow cytometry for their characterization and quantification.
- Open Access
- 1 January 2016
- Published by Wiley in Journal of Extracellular Vesicles
- Vol. 5 (1) , 29877
Energy‐requiring uptake of prostasomes and PC3 cell‐derived exosomes into non‐malignant and malignant cells
Epithelial cells lining the prostate acini release, in a regulated manner (exocytosis), nanosized vesicles called prostasomes that belong to the exosome family. Prostate cancer cells have preserved this ability to generate and export exosomes to the extracellular space. We previously demonstrated that human prostasomes have an ATP‐forming capacity. In this study, we compared the capacity of extracellular vesicles (EVs) to generate ATP between normal seminal prostasomes and exosomes secreted by PC3 cells (PC3 exosomes), a prostate cancer cell line. Proteomic analyses identified enzymes of the glycolytic chain in both prostasomes and PC3 exosomes, and we found that both of them were capable of generating ATP when supplied with substrates. Notably, the net production of extracellular ATP was low for prostasomes due to a high ATPase activity contrary to an elevated net ATP level for PC3 exosomes because of their low ATPase activity. The uptake of the 2 types of EVs by normal prostate epithelial cells (CRL2221) and prostate cancer cells (PC3) was visualized and measured, demonstrating differential kinetics. Interestingly, this uptake was dependent upon an ongoing glycolytic flux involving extracellular ATP formation by EVs and/or intracellular ATP produced from the recipient cells. We conclude that the internalization of EVs into recipient cells is an energy‐requiring process also demanding an active V‐ATPase and the capacity of EVs to generate extracellular ATP may play a role in this process.
- 1 January 2016
- Published by Wiley in Journal of Extracellular Vesicles
- Vol. 5 (1) , 29877
Open AccessEnergy‐requiring uptake of prostasomes and PC3 cell‐derived exosomes into non‐malignant and malignant cells
Epithelial cells lining the prostate acini release, in a regulated manner (exocytosis), nanosized vesicles called prostasomes that belong to the exosome family. Prostate cancer cells have preserved this ability to generate and export exosomes to the extracellular space. We previously demonstrated that human prostasomes have an ATP‐forming capacity. In this study, we compared the capacity of extracellular vesicles (EVs) to generate ATP between normal seminal prostasomes and exosomes secreted by PC3 cells (PC3 exosomes), a prostate cancer cell line. Proteomic analyses identified enzymes of the glycolytic chain in both prostasomes and PC3 exosomes, and we found that both of them were capable of generating ATP when supplied with substrates. Notably, the net production of extracellular ATP was low for prostasomes due to a high ATPase activity contrary to an elevated net ATP level for PC3 exosomes because of their low ATPase activity. The uptake of the 2 types of EVs by normal prostate epithelial cells (CRL2221) and prostate cancer cells (PC3) was visualized and measured, demonstrating differential kinetics. Interestingly, this uptake was dependent upon an ongoing glycolytic flux involving extracellular ATP formation by EVs and/or intracellular ATP produced from the recipient cells. We conclude that the internalization of EVs into recipient cells is an energy‐requiring process also demanding an active V‐ATPase and the capacity of EVs to generate extracellular ATP may play a role in this process.
- Open Access
- 1 November 2015
- Published by Elsevier in Molecular & Cellular Proteomics
- Vol. 14 (11) , 3015-3022
Proteomic Profiling of Detergent Resistant Membranes (Lipid Rafts) of Prostasomes
- 1 November 2015
- Published by Elsevier in Molecular & Cellular Proteomics
- Vol. 14 (11) , 3015-3022
Open AccessProteomic Profiling of Detergent Resistant Membranes (Lipid Rafts) of Prostasomes
- Open Access
- 10 September 2015
- Published by American Society of Hematology in Blood
- Vol. 126 (11) , 1379-1389
The polyphosphate–factor XII pathway drives coagulation in prostate cancer-associated thrombosis
Key Points: Polyphosphate-activated coagulation factor XII drives prostate cancer-associated venous thrombosis. Targeting the polyphosphate/factor XII pathway reduces procoagulant activity in prostate cancer patient plasma and may permit safe anticoagulation.
- 10 September 2015
- Published by American Society of Hematology in Blood
- Vol. 126 (11) , 1379-1389
Open AccessThe polyphosphate–factor XII pathway drives coagulation in prostate cancer-associated thrombosis
Key Points: Polyphosphate-activated coagulation factor XII drives prostate cancer-associated venous thrombosis. Targeting the polyphosphate/factor XII pathway reduces procoagulant activity in prostate cancer patient plasma and may permit safe anticoagulation.